Ann: Official Supplier and Research Partner - ONE Championship, page-73

I agree with 33c, because that would put us at around 200M MC, which is where Dr Sud's last performance rights are vested upon him. 200 Million MC is also the magic number because two of our most valued peers, BOT and AGH are that number or higher.

When we have completed all our trials and everything is exercised, I see NO reason why we should not be the same or if not HIGHER than them.
Already outlined why I think so some time ago and others agree.

I see no reason why we should not reach that valuation, either ALL MedCann companies are overvalued to the moon (Only if you go by financials) and the market and sector scream NO, which is fine, ride sentiment while its there, foolish to go against the roaring tide.
If that is not the case, which it really isn't at the moment... there is NO reason why IHL should not be worth the same as its peers when we EXECUTE what we have in the pipeline. Dr Sud and CannVaLate seem to think so as they aren't being paid ANYTHING in cash for their work with us to fund trials and give IP to US. These are the most prominent people in the Aussie MedCann show, PERIOD. If they believe, so will I.

To any nay-sayers that target IHL specifically, stick your gun at the entire sector because you don't have reasons besides no successful trial yet.
Key word is YET.
Honestly waiting for any opposing view that wouldn't be applicable to the entire sector. Haven't seen one yet....
Bite me.